How do we interpret these results when making treatment decisions? INTERLACE addresses the relatively lower risk locally advanced cervical cancer group when compared to KEYNOTE-A18 (no patients with ...

Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put two of the biopharma's programs on hold in response to a case of nerve disease from a former ...